Visolis

Using synthetic biology to manufacture carbon-negative materials

First Investment: 2017

With support from AI-powered high-throughput screening and data modeling, Visolis engineers microbial strains that efficiently produce desired molecules. Traditional chemical catalysis turns these products into carbon-negative, bio-based specialty materials for multiple end markets and industries, from cosmetics to cars.

Explore Companies

Radionetics Oncology

Discovering more precise ways to deploy radiopharmaceuticals against solid tumors

DVLP Medicines

Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing

Noetik

Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer

Solu Therapeutics

Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules